SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 777.03 |
| Enterprise Value ($M) | 811.58 |
| Book Value ($M) | 5.52 |
| Book Value / Share | 0.09 |
| Price / Book | 140.72 |
| NCAV ($M) | -75.70 |
| NCAV / Share | -1.19 |
| Price / NCAV | -10.26 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.37 |
| Return on Assets (ROA) | -0.22 |
| Return on Equity (ROE) | -2.73 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 2.21 |
| Current Ratio | 2.40 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 151.34 |
| Assets | 232.57 |
| Liabilities | 227.05 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 266.27 |
| Operating Income | -27.23 |
| Net Income | -50.42 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -18.00 |
| Cash from Investing | -4.82 |
| Cash from Financing | 47.41 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Medytox Inc. | 3.40 | -36.82 | |
| 13G/A | BlackRock, Inc. | 6.90 | 30.71 | |
| 13G/A | Nantahala Capital Management, LLC | 4.48 | -2.95 | |
| 13G/A | Tang Capital Management Llc | 7.70 | ||
| 13G/A | Perceptive Advisors Llc | 8.50 | 35.15 | |
| 13G/A | Stonepine Capital Management, LLC | 2.20 | -74.31 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 349,349 | 1,154,644 | 30.26 | |
| 126,993 | 568,367 | 22.34 | |
| 85,502 | 501,326 | 17.06 | |
| 53,668 | 386,664 | 13.88 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| CRVS – Corvus Pharmaceuticals, Inc. | CURR – CURRENC Group Inc. |
| CVAC – CureVac N.V. | ESPR – Esperion Therapeutics, Inc. |
| ETNB – 89bio, Inc. |
Financial data and stock pages provided by
Fintel.io